Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Huber

Showing results (451-460 of 633) with videos related to

Pageof 64
Sort By:
Nature Medicine|September 24, 2013
AKT2 is essential to maintain podocyte viability and function during chronic kidney diseaseGuillaume Canaud, Frank Bienaimé, Amandine Viau, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2023
Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ DamageMarlies Bode, Georg R Herrnstadt, Leonie Dreher, et al.
Journal of the American Society of Nephrology : JASN|April 6, 2016
Renal Atp6ap2/(Pro)renin Receptor Is Required for Normal Vacuolar H+-ATPase Function but Not for the Renin-Angiotensin SystemFrancesco Trepiccione, Simon D Gerber, Florian Grahammer, et al.
The Journal of Experimental Medicine|September 29, 2023
Retinoic acid drives intestine-specific adaptation of effector ILC2s originating from distant sitesNikhat Shaikh, Alex Waterhölter, Ann-Christin Gnirck, et al.
Nature Communications|May 20, 2025
Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in miceHuiying Wang, Jonas Engesser, Robin Khatri, et al.
JCI Insight|February 26, 2026
Functional characterization of podocyte-expressed THSD7A in experimental membranous nephropathyMing Huang, Moritz Lassé, Silke Dehde, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 26, 2026
Daratumumab as rescue therapy in refractory recurrent FSGS after kidney transplantation: a case seriesParthenopi Despina Avaniadi, Aylin Akifova, Eva Vanessa Schrezenmeier, et al.
Brain : a Journal of Neurology|July 17, 2009
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosisS Cotte, N von Ahsen, N Kruse, et al.
Leukemia|February 23, 2018
The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell functionJuliane Mohr, Banaja P Dash, Tina M Schnoeder, et al.
Developmental Cell|December 4, 2018
ARP3 Controls the Podocyte Architecture at the Kidney Filtration BarrierChristoph Schell, Benedikt Sabass, Martin Helmstaedter, et al.
Pageof 64

Showing results (451-460 of 633) with videos related to

Sort By:
Pageof 64
Nature Medicine|September 24, 2013
AKT2 is essential to maintain podocyte viability and function during chronic kidney diseaseGuillaume Canaud, Frank Bienaimé, Amandine Viau, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2023
Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ DamageMarlies Bode, Georg R Herrnstadt, Leonie Dreher, et al.
Journal of the American Society of Nephrology : JASN|April 6, 2016
Renal Atp6ap2/(Pro)renin Receptor Is Required for Normal Vacuolar H+-ATPase Function but Not for the Renin-Angiotensin SystemFrancesco Trepiccione, Simon D Gerber, Florian Grahammer, et al.
The Journal of Experimental Medicine|September 29, 2023
Retinoic acid drives intestine-specific adaptation of effector ILC2s originating from distant sitesNikhat Shaikh, Alex Waterhölter, Ann-Christin Gnirck, et al.
Nature Communications|May 20, 2025
Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in miceHuiying Wang, Jonas Engesser, Robin Khatri, et al.
JCI Insight|February 26, 2026
Functional characterization of podocyte-expressed THSD7A in experimental membranous nephropathyMing Huang, Moritz Lassé, Silke Dehde, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 26, 2026
Daratumumab as rescue therapy in refractory recurrent FSGS after kidney transplantation: a case seriesParthenopi Despina Avaniadi, Aylin Akifova, Eva Vanessa Schrezenmeier, et al.
Brain : a Journal of Neurology|July 17, 2009
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosisS Cotte, N von Ahsen, N Kruse, et al.
Leukemia|February 23, 2018
The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell functionJuliane Mohr, Banaja P Dash, Tina M Schnoeder, et al.
Developmental Cell|December 4, 2018
ARP3 Controls the Podocyte Architecture at the Kidney Filtration BarrierChristoph Schell, Benedikt Sabass, Martin Helmstaedter, et al.
Pageof 64